Seiichiro Yamamoto - Concepedia

Author

Seiichiro Yamamoto

Also Known As

Hideki Ohdan, Masazumi Okajima, S Yamamoto, S. YAMAMOTO, S. Yamamoto, SEIICHIRO YAMAMOTO, Seiichiro YAMAMOTO, Seiichiro Yamamoto, Shozo Yamamoto, Yamamoto Seiichiro

356

Publications

16.2K

Citations

H-Index

139

Concepts

All Affiliations

National Cancer Center Tokyo National Hospital National Cancer Center Hospital East National Cancer Centre Japan The University of Tokyo

About

Seiichiro Yamamoto is an author at National Cancer Center specializing in medicine, oncology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	62	5.7K
2	Health Sciences	11	11	732
3	Engineering	3	3	180
4	Natural Sciences	2	2	195
5	Nursing	1	1	15

Seiichiro Yamamoto

161

Publications

15.6K

Citations

H-Index

Page 1

	Year	Citations
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer Mitsuru Sasako, Takeshi Sano, Seiichiro Yamamoto, New England Journal of Medicine	2008	1K
Identification of Genes Upregulated in <i>ALK</i> -Positive and <i>EGFR/KRAS/ALK</i> -Negative Lung Adenocarcinomas Hirokazu Okayama, Takashi Kohno, Yuko Ishii, Cancer Research	2011	865
Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer Toshimi Takano, Yuichiro Ohe, Hiromi Sakamoto, Journal of Clinical Oncology	2005	706
Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501 Takeshi Sano, Mitsuru Sasako, Seiichiro Yamamoto, Journal of Clinical Oncology	2004	677
Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial Noriaki Ohuchi, Akihiko Suzuki, Tomotaka Sobue, The Lancet Breast OncologyCancer DetectionCancer ScreeningMedicineBreast Imaging	2015	591
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study Narikazu Boku, Seiichiro Yamamoto, Haruhiko Fukuda, The Lancet Oncology OncologyCisplatin Versus S-1Gastrointestinal OncologyMedicineRandomised Phase 3	2009	591
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial Mitsuru Sasako, Takeshi Sano, Seiichiro Yamamoto, The Lancet Oncology Surgical OncologyAbdominal-transhiatal ApproachGastrointestinal OncologyMedicineGastroenterology	2006	441
Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002 Elizabeth Horstmann, Mary S. McCabe, Louise B. Grochow, New England Journal of Medicine	2005	433
Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205) Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, Journal of Clinical Oncology	2002	431
Short-Term Surgical Outcomes From a Randomized Controlled Trial to Evaluate Laparoscopic and Open D3 Dissection for Stage II/III Colon Cancer Seiichiro Yamamoto, Masafumi Inomata, Hiroshi Katayama, Annals of Surgery	2014	346

Page 1